摘要
目的分析我国医药市场竞争性质。方法运用市场结构理论进行分析。结果我国医药市场就总体而言是不完全竞争市场 ,且竞争因素大于垄断因素。少数产品存在寡头垄断市场。结论随着我国加入WTO ,某些药品的寡头垄断因素将进一步降低。医药企业将面临更加激烈的竞争。为了应对这种挑战 ,医药企业必须通过技术创新、管理创新、制度创新 ,努力培育核心竞争力 ,才能在新经济条件下 ,即在知识经济、信息经济、网络经济、全球经济条件下立于不败之地。
Objective To exactly analyse the pharmaceutical market structure.Method the Theory of Market Structure was used to analyse the nature of the pharmaceutical market in China.Results We put fourward the conclusion: overall, the pharmaceutical market is an incomplete competitive market; furthermore, the competition factors exceed the monopoly factors. There are oligarchal monopoly parts of the pharmaceutical market for the minority of the pharmaceutical products.Conclusions Pharmaceutical enterprises will confront serious competitions. In order to face those challenges, the enterprises must make every effort to foster competitive abilities, through technology innovation, management innovation and system innovation. So the enterpries can indefectibly stand in new economy situation, which means knowledge economy, information economy, network economy and world wide economy.
出处
《沈阳药科大学学报》
CAS
CSCD
2002年第1期63-65,共3页
Journal of Shenyang Pharmaceutical University